Eupraxia Pharmaceuticals Inc. Brief: Says To Present Data From the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024
Eupraxia Pharmaceuticals Inc. Brief: Says To Present Data From the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024
Eupraxia药品公司简介:将在2024年欧洲风湿病学会议上展示第二阶段SPRINGBOARD研究中关于膝骨关节炎的数据。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册